4 found

Year:

  1. COVID-19 Vaccine Trial Ethics Once We Have Efficacious Vaccines.David Wendler, Jorge Ochoa, Joseph Millum, Christine Grady & Holly Taylor - 2020 - Science 370 (6522):1277-1279.
    Some placebo-controlled trials can continue ethically after a candidate vaccine is found to be safe and efficacious.
    Direct download  
     
    Export citation  
     
    Bookmark  
  2. Imaginary Demons and Scientific Discoveries. [REVIEW]Jan G. Michel - 2020 - Science 370 (6518):772.
  3.  54
    Improve Alignment of Research Policy and Societal Values.Peter Novitzky, Michael J. Bernstein, Vincent Blok, Robert Braun, Tung Tung Chan, Wout Lamers, Anne Loeber, Ingeborg Meijer, Ralf Lindner & Erich Griessler - 2020 - Science 369 (6499):39-41.
    Historically, scientific and engineering expertise has been key in shaping research and innovation policies, with benefits presumed to accrue to society more broadly over time. But there is persistent and growing concern about whether and how ethical and societal values are integrated into R&I policies and governance, as we confront public disbelief in science and political suspicion toward evidence-based policy-making. Erosion of such a social contract with science limits the ability of democratic societies to deal with challenges presented by new, (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  4. An Ethical Framework for Global Vaccine Allocation.Ezekiel J. Emanuel, Govind Persad, Adam Kern, Allen E. Buchanan, Cecile Fabre, Daniel Halliday, Joseph Heath, Lisa M. Herzog, R. J. Leland, Ephrem T. Lemango, Florencia Luna, Matthew McCoy, Ole F. Norheim, Trygve Ottersen, G. Owen Schaefer, Kok-Chor Tan, Christopher Heath Wellman, Jonathan Wolff & Henry S. Richardson - 2020 - Science 1:DOI: 10.1126/science.abe2803.
    In this article, we propose the Fair Priority Model for COVID-19 vaccine distribution, and emphasize three fundamental values we believe should be considered when distributing a COVID-19 vaccine among countries: Benefiting people and limiting harm, prioritizing the disadvantaged, and equal moral concern for all individuals. The Priority Model addresses these values by focusing on mitigating three types of harms caused by COVID-19: death and permanent organ damage, indirect health consequences, such as health care system strain and stress, as well as (...)
    Direct download  
     
    Export citation  
     
    Bookmark   6 citations  
 Previous issues
  
Next issues